Inhibition of angiogenesis

Details Inhibition of angiogenesis Inhibition of angiogenesis

A - Human Necessities

61

K

A61K 47/36 (2006.01) A61K 31/19 (2006.01) A61K 31/195 (2006.01) A61K 31/215 (2006.01) A61K 31/40 (2006.01) A61K 31/405 (2006.01) A61K 31/44 (2006.01) A61K 31/54 (2006.01) A61K 31/60 (2006.01) A61K 31/715 (2006.01) A61K 45/00 (2006.01) A61P 29/00 (2006.01) A61P 43/00 (2006.01) C07C 229/40 (2006.01) C08B 37/08 (2006.01)

Patent

CA 2094203

ABSTRACT A pharmaceutical composition comprising a plurality of effective non-toxic dosage amounts of a composition for administration to a mammal for the inhibition of angiogenesis, each such dosage amount comprising a therapeutically effective non-toxic (to the patient) dosage amount of an non-steroidal anti-inflamatory drug and an effective non-toxic dosage amount of hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments, and/or sub-units of hyaluronic acid to inhibit angiogenesis in the patient.

Affiliated with

Also associated with

Rating

Inhibition of angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of angiogenesis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1575363